Our proposed research project aims to answer the overall question: what is the actual risk of infections or cardiovascular events for patients with inflammatory arthritis that take novel arthritis medication (biologics) and how does it compare between different classes of these drugs, in real-world settings? As well as asking if the safety and effectiveness of […]
Read More